Sanara Medtech Inc (SMTI)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sanara Medtech Inc Stock (SMTI) Company Profile

Sanara Medtech Inc

Healthcare (1100)

817-529-2300

1200 SUMMIT AVE, FORT WORTH

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SMTI's Discussions on Twitter

Compare SMTI vs ISRG, BDX, MDLN, ALC, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SMTI Sanara Medtech Inc	25.12	227.63M	103.14M	-5.82M	2.14M	-4.3526
ISRG Intuitive Surgical Inc	426.49	150.88B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	157.46	43.56B	21.37B	1.41B	3.07B	3.9437
MDLN Medline Inc	42.81	36.52B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	67.22	33.97B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	219.34	30.41B	5.54B	1.52B	1.74B	10.37

Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-15	Eingeleitet	Lake Street	Buy
2025-03-26	Bestätigt	H.C. Wainwright	Buy
2024-12-23	Eingeleitet	H.C. Wainwright	Buy
2022-05-20	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-06-30	Eingeleitet	Cantor Fitzgerald	Overweight

Sanara Medtech Inc Aktie (SMTI) Neueste Nachrichten

Finanzdaten der Sanara Medtech Inc-Aktie (SMTI)

Sanara Medtech Inc (SMTI)

Sanara Medtech Inc Stock (SMTI) Company Profile

Compare SMTI vs ISRG, BDX, MDLN, ALC, RMD

Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades

Sanara Medtech Inc Aktie (SMTI) Neueste Nachrichten

Sanara MedTech Inc outlines its wound care focus. Longer-term growth story draws investor interest - AD HOC NEWS

Price to sales forward of Sanara MedTech Inc. – BOATS:SMTI - TradingView

Price to book forward of Sanara MedTech Inc. – NASDAQ:SMTI - TradingView

Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review

Sanara MedTech (SMTI) Surges 2.35% as Bulls Test Resistance at $26.08Change of Character - dars.gov.et

How Sanara Medtech Inc. (SMTI) Affects Rotational Strategy Timing - Stock Traders Daily

Sanara MedTech, Inc. Actuals & Estimates (NASDAQ:SMTI) - TradingView

SMTI Forecast — Price Target — Prediction for 2027 - TradingView

Sanara Medtech Inc (SMTI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth - Yahoo Finance

Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Sanara Medtech Inc (SMTI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Sanara Medtech Inc (SMTI) Institutional Confidence - TradingKey

Sanara Medtech Inc (SMTI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Sanara Medtech Inc (SMTI) Valuation: PE, PB & Fair Value Analysis - TradingKey

SMTI Initiates Coverage by Freedom Broker -- Rating Set to Buy - GuruFocus

Freedom Broker initiates Sanara MedTech stock with buy rating, $35 target - Investing.com UK

(SMTI) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Sanara Medtech Inc (SMTI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Sanara Medtech Inc (SMTI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Sanara Medtech Inc (SMTI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Sanara MedTech (SMTI) Rallies 3.68% as Shares Approach Resistance ZoneDollar Neutral Pair - dars.gov.et

Sanara MedTech (SMTI) Slips 3.2% as Stock Tests Key Support LevelsDark Pool Sentiment - newsline.com

Sanara MedTech Inc. (SMTI) Tops Q3 Earnings Estimates - MSN

Sanara MedTech Shareholders Reaffirm Board and Governance Policies - TipRanks

Sanara MedTech (SMTI) investors approve board, auditor and 3-year say-on-pay cycle - Stock Titan

Responsive Playbooks and the SMTI Inflection - Stock Traders Daily

[Form 4] Sanara MedTech Inc. Insider Trading Activity - Stock Titan

Sanara MedTech (SMTI) director receives 4,154 restricted shares, total holdings 26,858 - Stock Titan

Sanara MedTech (SMTI) director awarded 5,308 restricted shares vesting in 2027 - Stock Titan

Sanara MedTech (SMTI) director granted 4,616 restricted stock shares under 2024 plan - Stock Titan

Sanara MedTech Ends Catalyst Advisory Deal, Refocuses Strategy - TipRanks

Sanara Medtech Terminates Services Agreement With Catalyst Effective June 2 - TradingView

Sanara MedTech Ends Advisory Services Agreement With The Catalyst Group Amid Strategy Shift - TradingView

Sanara MedTech (NASDAQ: SMTI) terminates Catalyst advisory agreement - Stock Titan

Sanara MedTech (SMTI) Q1 2026 Earnings Transcript - AOL.com

Sanara MedTech (SMTI) Q1 2026 Earnings Transcript - The Motley Fool

SMTI Stock Price, Quote & Chart | SANARA MEDTECH INC (NASDAQ:SMTI) - ChartMill

Sanara MedTech Inc. (SMTI) Slides as Support Test Looms; Medtech Sector Sentiment WeighsIchimoku Entry - The Legal Advocate

Sanara MedTech (SMTI) Falls 4.2% as Selling Pressure Intensifies Near SupportEarnings Beat Stocks - dars.gov.et

Sanara MedTech (SMTI) Gains 1.75% as Stock Tests Key Resistance LevelGEX Level - newsline.com

Sanara MedTech (SMTI) Q4 2025 Earnings Transcript - AOL.com

Understanding the Setup: (SMTI) and Scalable Risk - Stock Traders Daily

SMTISanara MedTech Inc Stock Price and Quote - Finviz

Sanara MedTech Dips After Swing to Profit - Bez Kabli

Sanara MedTech (SMTI) Edges Lower Amid Modest Trading, Holds Above Key SupportMarket Leader Picks - The Legal Advocate

Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put - Yahoo Finance

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Shareholders to Connect - ACCESS Newswire

Sanara MedTech (SMTI) Q1 2026 Earnings: EPS $0.05 Beats EstimatesReturn On Equity - The Legal Advocate

Sanara MedTech (SMTI) Q1 2026 Earnings Beat: Revenue $N/A, EPS $0.05Viral Trade Signals - Newser

Finanzdaten der Sanara Medtech Inc-Aktie (SMTI)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SMTI